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Replication of smooth muscle cells (SMCs) is
prominent during the arterial response to injury and is
one of the hallmarks of pathologic vessel-wall healing.
Proliferative lesions are seen not only in accelerated
forms of arterial narrowing, such as anastomotic inti-
mal hyperplasia and restenosis after angioplasty, but
also in chronic atherosclerosis.1-3 After arterial injury,
cytokines and growth factors produced as part of the
initial thrombotic and inflammatory response induce
quiescent medial SMCs to enter the cell cycle and pro-
liferate.4 Progression through the cycle, however, is
controlled by a series of cyclins, cyclin-dependent
kinases (CDKs), and CDK inhibitors (CDKIs).5 Cell-
cycle progression requires complexation of a cyclin
and CDK. Activity of these cyclin-CDK complexes can
be altered by CDKIs, which bind to and inactivate
cyclin-CDK complexes, arresting the cell cycle.6 Cell-
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cycle arrest can redirect the cell toward apoptotic path-
ways.7 Therefore, levels of these regulatory molecules
influence quiescence, proliferation, and apoptosis in a
cell population. In the injured arterial wall, the balance
between proliferation and apoptosis rates has potential
effects on both neointimal formation and remodeling. 
Among inhibitors of cell-cycle progression, p27,
a CDKI implicated in cell-cycle arrest induced by
transforming growth factor-beta, cell-to-cell con-
tact, and serum deprivation, is considered a major
regulator of G1/S transition.8 Like other members
of the Cip/Kip family, including p21 and p57, p27
is ubiquitous; however, it binds preferentially to G1
cyclin-CDK complexes.5,9 A role in modulating
apoptosis also has been proposed on the basis of
studies using p27-deficient fibroblasts and mesangial
cells.10 The inhibitory effect of p27 on proliferation
has been shown in vascular SMC.11
Although the importance of studying molecular
targets with potential to alter the proliferative
response has become increasingly clear, lack of appro-
priate in vivo models has limited such studies.12
Therefore, expressions of p27 and Ki67 (a marker of
proliferation), as well as apoptosis, were analyzed in a
mouse model of transluminal arterial injury.13,14 This
model, described recently, simulates many aspects of
human restenosis, and could be beneficial as a means
of investigating molecular events involved in the
restenotic process in genetically modified mice. This
study, using wild-type mice, demonstrates the
sequential expression of cell-cycle regulation markers
during the vessel wall response to injury, and vali-
dates mouse femoral arterial injury as an experimen-
tal tool to examine such events.
METHODS 
Animals. A total of 20 wild-type mice of the inbred
strain, C57BL/6 (Taconic Farms, Germantown, NY)
were used. (This strain is common as background in
transgenic and knockout mice.) Mice were housed at
the Center for Laboratory Animal Sciences, The
Mount Sinai Medical Center, NY, and received a stan-
dard rodent chow (PMI Nutrition International, St
Louis, Mo) and tap water ad libitum. Animal care and
experimental procedures conformed with the “Guide
for the Care and Use of Laboratory Animals”
(Department of Health, Education, and Welfare,
Publication No NIH 78-23, 1996), and were approved
by the Institutional Animal Care and Use Committee.
Experimental design. Histologic sections of
mouse arteries obtained at various time points after
injury were examined to determine the time course
of cell-cycle markers and apoptotic cell death in the
arterial wall. Specimens noted to be inadequate for
histologic analysis (n = 2) or containing arteries with
occlusive thrombus (n = 4) were excluded. Arteries
harvested at 1 (n = 2), 6 (n = 2), 12 (n = 2), 24 (n
= 2), and 48 (n = 2) hours, and 7 (n = 9), 14 (n =
6), and 28 (n = 5) days after injury were analyzed.
Expressions of p27 and Ki67, as well as apoptosis,
were determined, correlated with histology, and
compared with normal, uninjured arteries (n = 4)
used as controls, representing baseline values.
Arterial injury protocol. Male mice, 3 to 4
months old (weight, approximately 25 g), were used.
Bilateral femoral arterial injury was performed as
described.14 Mice were anesthetized with pentobarbi-
tal (40 mg/kg body weight, intraperitoneal;
Nembutal, Abbott Laboratories, North Chicago, Ill),
and placed in the supine position with lower extremi-
ties extended. The surgical procedures were per-
formed under magnification, using a surgical micro-
scope (Carl Zeiss, Thornwood, NY). A groin incision
was made, and the segment of femoral artery between
epigastric and saphenous arteries was dissected free
from the vein. (For anatomy of mouse femoral vessels,
see Zhang et al.15) After the femoral vessels were
clamped at the level of the inguinal ligament, an arte-
riotomy was made on the femoral artery, approximate-
ly 1 mm distal to the epigastric branch. A 0.010-in
(0.25-mm) diameter angioplasty guidewire (Advanced
Cardiovascular Systems, Temecula, Calif) was intro-
duced into the arterial lumen, the clamp removed, and
the wire advanced and pulled back three times, each
time reaching the aortic bifurcation. The wire was then
removed, and arteriotomy site ligated with 8-0 nylon
sutures (U.S. Surgical, Norwalk, Conn). The same
protocol was carried out on the contralateral side.
Histology, immunohistochemistry, and apop-
tosis assessment. For harvesting of specimens, after
deep anesthesia with pentobarbital (50 mg/kg body
weight), mice were perfusion fixed with 4%
paraformaldehyde in phosphate-buffered saline
(PBS, pH = 7.4) solution at 100 mm Hg for 5 min-
utes. The perfusate was infused through a cannula
(18 ga; Angiocath, Becton Dickinson, Sandy, Utah)
inserted in the left ventricle, and drained through an
incision in the right atrium. The hindlimbs and pelvis
were excised en bloc, fixed in 4% paraformaldehyde
in PBS solution overnight, and decalcified in 10%
formic acid for 24 hours. The thighs, containing the
femoral vessels, were cut transversely; the common
femoral artery (approximately 4-mm length from
inguinal ligament to epigastric branch) was divided
into 2-mm segments. Specimens underwent standard
dehydration and paraffin embedding. Sequential
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cross-sections (thickness: 5 µm) cut from the mid-
portion of the femoral artery were stained with com-
bined Masson-elastic (CME)16 and hematoxylin-
eosin, or processed for immunohistochemistry.
Representative sections were treated with antibod-
ies to Ki67 (1:1000; rabbit polyclonal, NovoCastra,
Newcastle, UK), p27Kip1 (1:30,000; affinity purified
rabbit polyclonal antibody against murine p27 fusion
protein; provided by Dr A. Koff, Memorial Sloan-
Kettering Cancer Center, New York, NY), factor VIII-
related antigen (Rabbit Anti-Human Von Willebrand
Factor [vWF], Dako, Denmark; 0.57 µg/mL), and α-
actin (alkaline-phosphatase-conjugated monoclonal
anti-α-smooth muscle actin; 1:100; Sigma, St Louis,
Mo). Sections were immersed in boiling 0.01 mol/L
citric acid (pH 6.0) for 15 minutes for antigen
retrieval, and incubated with primary antibodies
overnight at 4°C. Biotinylated goat antirabbit IgG
antibodies were applied for 1 hour (1:500; Vector
Laboratories, Burlingame, Calif), followed by avidin-
biotin peroxidase complexes for 30 minutes (1:25;
Vector Laboratories). Diaminobenzidine was used as
final chromogen, and hematoxylin for nuclear coun-
terstaining. Negative controls were prepared by substi-
tuting the primary for an irrelevant antibody. Positive
control for Ki67 was mouse lymph node; for p27,
mouse thymus; for vWF, normal-artery endothelium;
and for α-actin, normal-artery media.
For the assessment of apoptosis, sections were
stained by a terminal deoxytransferase-mediated dUTP-
biotin nick end-labeling (TUNEL) assay, modified from
that described by Gavieli et al.17 This noncommercial
assay is based on specific binding of terminal deoxinu-
cleotinyl transferase (TdT) to 3´-OH ends of DNA to
ensure synthesis of a polydeoxynucleotide. After expo-
sure of nuclear DNA of histologic sections by treatment
with 20 µg/mL proteinase K, TdT buffer was applied
for 15 minutes. A reaction mixture of 0.1 mmol/L
DDT, 0.5 µL TdT, and 0.07 mmol/L biotin-11 dUTP
was applied for 1 hour to promote insertion of biotiny-
lated deoxyuridine at sites of DNA breaks. The signal
was amplified by avidin-biotin peroxidase complexes for
30 minutes and visualized by diaminobenzidine deposi-
tion to allow histochemical identification of reactive
nuclei by light microscopy—brown staining, in contrast
with nonimmunoreactive, hematoxylin counterstained,
blue nuclei. Positive controls for TUNEL were moder-
ately (2 rads) and severely (10 rads) irradiated mouse
thymuses harvested 8 hours after irradiation.
Analysis of histologic cross sections. Each
cross-section was analyzed by two separate investiga-
tors in a blind coded fashion. For computerized
morphometry,18 images were captured from a video
camera attached to a light microscope, and digi-
tized. The two CME-stained cross-sections from
each artery were measured (NIH Image 1.60 soft-
ware) and results averaged. Luminal area (LA), the
area bounded by internal elastic lamina (IEL) that
corresponds to the LA in the absence of intimal
lesions, and the area encircled by external elastic
lamina (EEL) that corresponds to overall vessel size,
were obtained. Derived calculations included media
area (EEL area minus IEL area), intimal area (IA;
IEL area minus LA), and percentage of luminal nar-
rowing ([IA/IA+LA] × 100).
Immunohistochemistry for p27 and Ki67 was
assessed at ×400 magnification. Given the small size
of mouse arteries, all cells in the media, neointima,
and endothelium were counted. Cells with positive
nuclear immunoreactivity (brown staining) were
scored, and the percentage of positive cells relative
to total number of nuclei was calculated.
Endothelial coverage (low-profile cells with cen-
tral nuclei coating the luminal surface) was assessed
on sections stained for vWF and CME. The length
of the monolayer of endothelial cells also was mea-
sured, and divided by the length of luminal surface.
Statistics. Numeric data are expressed as mean ±
SEM. Analysis of variance (ANOVA) was used to
determine differences among results of the various
time points. Student t test was used for comparisons
between two different time points. P values less than
.05 were considered significant.
RESULTS
Endothelial denudation and neointimal for-
mation. Histomorphometric data on injured arter-
ies are summarized in the Table. Early after injury,
arteries displayed complete endothelial denudation.
Progressive endothelial coverage (percent of luminal
surface on cross section) was observed, and com-
plete reendothelialization was reached by 28 days.
Intimal hyperplasia, defined as any proliferative
lesion within the internal elastic lamina circumfer-
ence, was absent at early time points, and increased
gradually from 7 to 28 days. Mean intima-to-media
(I/M) ratio of 1.1 ± 0.1, and luminal narrowing of
23% ± 3% were obtained by day 28. SMC was the
major cell type within the neointima, as confirmed
by α-actin staining.
Time course of apoptosis in the vessel wall.
Apoptosis was absent in uninjured vessels. After
injury, apoptosis was noted as early as at 1 hour.
Highest apoptotic rates were noted from 6 to 24
hours (P < .05 vs controls) in the media, and
remained elevated from 1 to 7 days. At 14 days,
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whereas medial apoptotic index had decreased, high
levels (32%) of apoptosis were observed in the devel-
oping neointima. In the endothelium, apoptosis
rates were low-to-undetectable throughout the 4-
week period. The distribution of apoptosis in the
femoral arterial wall at representative time intervals
after injury is illustrated in Figs 1, A, and 2, A.
Morphology and comparison with α-actin-stained
sections indicated most apoptotic cells were SMC.
Time course of cell proliferation. Ki67 is a
marker of proliferation expressed in all phases of the
cell cycle. Uninjured arteries expressed Ki67 in less
than 5% of medial cells. The endothelium displayed
higher proliferative index, with 21% Ki67-positive
Fig 1. Temporal sequence of cell cycle markers in mouse
femoral arterial wall after transluminal wire injury. A,
Apoptosis; B, Ki67 proliferative index; and C, p27 expres-
sion. Each curve represents mean values for percentage of
positively stained cells within a layer of the vessel wall;
standard error represented by vertical bars.
Fig 2. Representative photomicrographs of mouse femoral
artery cross sections at different time points after translu-
minal wire injury. A, Apoptosis 12 hours after injury; B,
Ki67 expression 2 weeks after injury; and C, p27 expres-
sion 4 weeks after injury. Immunoreactive nuclei are iden-
tified by brown staining (arrowheads). Note intimal hyper-
plasia lesions at 2 and 4 weeks (B and C, respectively).
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cells. No significant Ki67 expression was found in
the vessel wall by 24 hours after injury. By 7 days,
proliferative activity was noted in the media, neoin-
tima, and endothelium (P = NS), reaching maximal
levels at 14 days (P < .05 vs controls). At 28 days,
Ki67 expression was decreased in all layers to levels
comparable to baseline (Figs 1, B, and 2, B). 
Time course expression of p27. p27 was pre-
sent in less than 5% of medial SMC in uninjured
arteries. After injury, p27 was absent between 1 and
48 hours. A gradual increase in p27 expression was
observed in all layers of the vessel wall from 7 to 28
days following injury. At 7 days, p27 was found in
medial SMCs and regenerated endothelium (P = NS
vs controls). At 14 days, expression levels were high-
er throughout the vessel wall (P < .05 vs controls),
including a small percentage of cells in the develop-
ing neointima. By 28 days, p27 reached highest lev-
els of expression in the media and neointima (P <
.05 vs controls) (Figs 1, C, and 2, C). 
Temporal sequence of apoptosis, prolifera-
tion, and p27 expression. An acute and transient
increase in apoptosis occurred after injury, followed
by high proliferation rates, which later also declined.
Increased levels of p27 expression found toward late
phases suggest upregulation of p27 modulates the
inhibitory response to proliferation. After the peak
of apoptosis (6 hours after injury), a gradual
decrease in apoptotic rates was paralleled by pro-
gressive increase in Ki67 proliferative index from 1
day to 1 week. At 2 weeks, cell proliferation peaked
(26% ± 5%), associated with a second peak of apop-
tosis (28% ± 4%), primarily in the neointima.
Equilibrium between apoptosis (15% ± 6%) and pro-
liferation (11% ± 3%) was maintained at 4 weeks.
p27 expression peaked at 2 weeks (18 ± 3%), and
persisted high by 4 weeks (16% ± 5%), concomitant
with the decreasing proliferative index. Temporal
expression of these markers in the femoral arterial
wall is illustrated in Fig 3.
DISCUSSION
Interest in the response to arterial injury in mice
has grown as a result of the increasing availability of
genetically modified mice, which represent useful
systems to study specific molecules in vivo.19,20 This
study was designed to determine the temporal
expression of cell-cycle markers in the mouse arteri-
al wall during neointimal formation. At early time
points after femoral artery denudation, a prominent
apoptotic response occurred, whereas proliferation
and p27 expression were absent. After the first week,
a proliferative response ensued (increasing Ki67 lev-
els), accompanied by increasing expression of p27.
High p27 levels were associated with decreased pro-
liferation rates. In combination, these findings sug-
gest p27 upregulation as a mechanism of controlling
proliferation during vessel-wall healing.
The technique of injury to the femoral artery
used in this study results in substantial amounts of
intimal hyperplasia and is highly reproducible.13,14
In this model, the endothelium is denuded by
Fig 3. Time course of p27 expression, Ki67 proliferative index, and apoptosis in the full-thickness arter-
ial wall after transluminal injury. Results represent percentage of cells with positive nuclear immunoreac-
tivity (mean ± SEM).
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repeated passage of an angioplasty guidewire. The
time course of neointimal formation is similar to that
reported after balloon injury in rabbits,21 pigs,22 and
baboons.23 I/M ratios also are comparable with
those obtained in larger animals.2 As in other mod-
els, and in some cases of human restenosis, favorable
remodeling also has been noted in this model.14
Although other techniques of injury have been
described in mice, most of them use external
approaches (eg, periarterial cuff,24 electric current,25
or arterial ligature26) and, thus, differ from usual
clinical scenarios in which injury is transluminal, as
in balloon angioplasty of coronary or peripheral
arteries. One exception, wire denudation of the
mouse carotid,27 is considered difficult technically,
and is prone to variability.28
The enzymatic activity of cyclin-CDK complexes is
modulated by binding of CDKIs.8 Cyclin-CDK com-
plexation allows hyperphosphorylation of retinoblas-
toma protein and release of E2F transcription factor,
essential for progression through S phase. The transi-
tion between G1 (protein synthesis) and S (DNA syn-
thesis) phases is critical because cell-cycle progression
becomes irreversible after the G1 restriction point; the
cell either replicates or undergoes apoptotic death. p27
is one of the principle negative regulators of cell-cycle
progression, inhibiting a variety of cyclin-CDK com-
plexes throughout the cell cycle.5 Intracellular levels of
free p27 determine the threshold for cell entry into S
phase.29 Altered expression of p27 occurs in many pro-
liferative disorders, including cancer,30 where p27 over-
expression is thought of as a defense mechanism against
excessive proliferation.31,32 Genetically modified mice
lacking p27 function have accelerated growth, multiple
organ hyperplasia, and a high incidence of tumors.33
Cell death can occur by two distinct processes,
either necrosis or apoptosis. Necrosis defines passive
cell death with loss of membrane integrity and
marked inflammatory response. Apoptosis is an
active process involving preprogramed intracellular
signaling, which leads to cell phagocytosis without
inflammatory reaction. Apoptosis is a homeostatic
process that helps maintain cell mass and tissue
structure; cell proliferation is compensated by loss
due to apoptosis under normal conditions.7 In
chronic atherosclerosis, apoptosis rates are higher in
SMCs within fibroproliferative lesions than in nor-
mal medial layers, which may contribute to plaque
instability.34 A rapid and prominent rise in medial
SMC apoptosis was found in the current study;
apoptosis was detected as early as 6 hours after
injury. As the healing response continued, prolifera-
tion ensued and apoptotic rates decreased gradually.
This early and transient apoptotic response also has
been described after rat carotid balloon denuda-
tion,35 and pig coronary angioplasty.36 In the pig
coronary artery, early apoptosis is seen primarily in
the media bordering the lumen, consistent with a
more severe damage to inner medial layers associat-
ed with transluminal injury.
Ki67 proliferative index increased after the peak
of apoptosis and decreased in later phases, concomi-
tant with increased expression of p27. Distribution of
proliferating SMC, as assessed by Ki67 immuno-
staining, indicates the progressive increase in prolifer-
ation peaks between 7 to 14 days after injury. Using
tritiated thymidine, Lindner et al27 reported highest
replication rates by the second week after carotid
injury in mice. This earlier peak may represent a dif-
ferent response of carotids compared with femoral
arteries.37 Between 2 and 4 weeks, an equilibrium
between proliferation and apoptosis rates was
observed in the current study. This finding is consis-
tent with previous studies suggesting the number of
cells does not increase significantly in later stages of
vascular repair.2 Decreased proliferation was associat-
ed with raising expression of p27, consistent with its
expected negative regulatory effect on cell-cycle pro-
gression. Levels above baseline were reached and
appeared to stabilize by 28 days, as if the homeosta-
tic balance in the vessel wall had been reestablished.
Similar patterns of expression have been described in
experimental arterial injury, such as in the pig
iliofemoral artery11,38 and rat carotid,6 supporting
the concept that p27 functions as an inhibitor of pro-
liferation in late phases of arterial repair.32
In summary, this study shows that transluminal
arterial injury induces a rapid apoptotic response,
Histology and morphometry of mouse femoral arteries after transluminal endothelial denudation
7 d 14 d 28 d
Variables (n = 9) (n = 7) (n = 5)
Endothelial coverage (%) 28 ± 3.7 49 ± 1.7 91 ± 1.8
Intimal area (µm2) 1833 ± 589 5046 ± 1187 11624 ± 4289
Luminal narrowing (%) 4 ± 2 14 ± 5 30 ± 12
Intima/media ratio 0.2 ± 0.07 0.3 ± 0.1 1.3 ± 0.5
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followed by progressive increase in SMC prolifera-
tion. As the healing process advances, including
development of a neointima, p27 is upregulated,
which suggests a role in controlling the ensuing pro-
liferation and reestablishing quiescent phenotype. In
the mouse, the temporal sequence of expression of
these markers resembles composite curves of various
studies using other animal models,39 which indicates
levels of expression of cell-cycle regulatory mole-
cules after arterial injury follow a predictable course
across species. Therefore, these experiments validate
femoral arterial injury in the mouse as a model for
studying intimal hyperplasia and, in particular, inter-
actions between promitogenic and antimitogenic
stimuli within the vessel wall during the response to
injury. Application of this injury model in genetical-
ly modified mice should help further define cell-
cycle regulatory pathways participating in arterial
stenosis and restenosis.
Thanks to Maria S. Jiao for assistance in TUNEL
assays, and Gae O. Decker-Garrad for editorial assistance.
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